Draft Discussion Points and Questions to the Committee

First Page		Document Content
Amgen Growth factors Radiobiology Filgrastim Chemotherapy Effective dose Bone marrow suppression Medical imaging Medicine Hematology Oncology		Draft Discussion Points and Questions to the Committee Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 77,79 KB Share Document on Facebook

	PDF Document DocID: 1xHCw - View Document
	PDF Document DocID: 1xCqd - View Document
	PDF Document DocID: 1xxr4 - View Document
	PDF Document DocID: 1xfK3 - View Document
	PDF Document DocID: 1x8yx - View Document